DermTech, Inc. (DMTKQ)

DermTech Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	31.05	40.21	81.25	179.91	24.25	15.37
Short-Term Investments	11.4	19.12	48.41	48.45	39.53	0
Cash & Cash Equivalents	42.45	59.33	129.66	228.36	63.78	15.37
Cash Growth	-60.80%	-54.24%	-43.22%	258.05%	314.84%	223.46%
Receivables	2.5	2.58	4.17	3.85	1.48	0.68
Inventory	0.83	1	1.76	0.48	0.1	0.04
Other Current Assets	-1.58	-1.17	0.45	0.14	1.52	1.06
Total Current Assets	44.2	61.75	136.04	232.82	66.88	17.15
Property, Plant & Equipment	55.3	56.71	62.38	12.29	2.73	0.98
Other Long-Term Assets	3.47	3.47	3.66	3.19	0.17	0.08
Total Long-Term Assets	58.77	60.18	66.04	15.49	2.9	1.06
Total Assets	102.97	121.93	202.08	248.31	69.78	18.21
Accounts Payable	1.91	1.48	2.42	2.88	1.57	1.61
Deferred Revenue	0.2	0.2	0.11	1.38	1.54	1.39
Current Debt	3.21	3.09	1.75	1.57	0.11	0
Other Current Liabilities	7.19	8.68	11.36	6.35	2.2	2.72
Total Current Liabilities	12.52	13.45	15.64	12.18	5.43	5.72
Long-Term Debt	50.46	51.31	54.08	6.28	0.23	0
Other Long-Term Liabilities	0	0	0.01	0.15	2.29	0
Total Long-Term Liabilities	50.46	51.31	54.09	6.43	2.52	0
Total Liabilities	62.98	64.76	69.72	18.61	7.94	5.72
Total Debt	53.67	54.39	55.83	7.86	0.34	0
Debt Growth	-3.44%	-2.57%	610.50%	2245.67%	-	-
Retained Earnings	-443.95	-423.94	-323.05	-206.36	-128.03	-91.11
Comprehensive Income	0.18	0.18	-0.77	-0.12	-0	0
Shareholders' Equity	39.99	57.18	132.35	229.7	61.84	12.49
Net Cash / Debt	-11.22	4.94	73.83	220.5	63.44	15.37
Net Cash / Debt Growth	-	-93.31%	-66.52%	247.56%	312.66%	-
Net Cash Per Share	-0.32	0.15	2.46	7.63	3.74	2.19
Working Capital	31.68	48.31	120.4	220.64	61.46	11.43
Book Value Per Share	1.15	1.75	4.41	7.95	3.64	1.78

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).